Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Control of salicylate intolerance with fish oils.
Healy E, Newell L, Howarth P, Friedmann PS. Healy E, et al. Among authors: howarth p. Br J Dermatol. 2008 Dec;159(6):1368-9. doi: 10.1111/j.1365-2133.2008.08830.x. Epub 2008 Sep 15. Br J Dermatol. 2008. PMID: 18795922
Summary of the conclusions.
Holgate ST, Church MK, Howarth PH, Simons FE, Campbell A, Dunn N, Routledge P, Hindmarch I I, Timmerman H, Camm J, Friedmann P, Canonica W, Scadding G, Devalia J, Renwick A. Holgate ST, et al. Among authors: howarth ph. Clin Exp Allergy. 1999 Jul;29 Suppl 3:IV-VI. Clin Exp Allergy. 1999. PMID: 10444247 No abstract available.
Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma.
Lee JK, Pollard SJ, Liu MC, Schleich F, Pelaia G, Almonacid C, Heaney LG, Chaudhuri R, Alfonso-Cristancho R, Zhang L, Maxwell A, Howarth P. Lee JK, et al. Among authors: howarth p. Ann Allergy Asthma Immunol. 2025 Jan 11:S1081-1206(25)00003-1. doi: 10.1016/j.anai.2025.01.002. Online ahead of print. Ann Allergy Asthma Immunol. 2025. PMID: 39805551
Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study.
Sands J, Ahn MJ, Lisberg A, Cho BC, Blumenschein G Jr, Shum E, Pons Tostivint E, Goto Y, Yoh K, Heist R, Shimizu J, Lee JS, Baas P, Planchard D, Pérol M, Felip E, Su WC, Zebger-Gong H, Lan L, Liu C, Howarth P, Chiaverelli R, Paz-Ares L. Sands J, et al. Among authors: howarth p. J Clin Oncol. 2025 Jan 6:JCO2401349. doi: 10.1200/JCO-24-01349. Online ahead of print. J Clin Oncol. 2025. PMID: 39761483
Clinical importance of patient-reported outcome measures in severe asthma: results from U-BIOPRED.
Meys R, Franssen FME, Van 't Hul AJ, Bakke PS, Caruso M, Dahlén B, Fowler SJ, Geiser T, Howarth PH, Horváth I, Krug N, Behndig AF, Singer F, Musial J, Shaw DE, Montuschi P, Zee AHM, Sterk PJ, Roberts G, Kermani NZ, Incalzi RA, Louis R, Andersson LI, Wagers SS, Dahlén SE, Chung KF, Adcock IM, Spruit MA; U-BIOPRED Study Group. Meys R, et al. Among authors: howarth ph. Health Qual Life Outcomes. 2024 Dec 20;22(1):109. doi: 10.1186/s12955-024-02321-3. Health Qual Life Outcomes. 2024. PMID: 39707320 Free PMC article.
A RESPONSE to anti-IL-5 therapy in comorbid patients with chronic rhinosinusitis with nasal polyps and severe asthma: Study protocol.
Bakakos P, Alobid I, Constantinidis J, Hellings P, Pfaar O, Taillé C, Bañas-Conejero D, Kallinikou K, Howarth P, Schleich F. Bakakos P, et al. Among authors: howarth p. J Allergy Clin Immunol Glob. 2024 Sep 17;4(1):100343. doi: 10.1016/j.jacig.2024.100343. eCollection 2025 Feb. J Allergy Clin Immunol Glob. 2024. PMID: 39554605 Free PMC article.
481 results